pyrazines has been researched along with glyx-13 peptide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burgdorf, J; Cearley, C; Gross, AL; Houck, DR; Khan, MA; Kroes, RA; Madsen, TM; Moskal, JR; Stanton, PK; Zhang, XL | 1 |
1 other study(ies) available for pyrazines and glyx-13 peptide
Article | Year |
---|---|
NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and Memory.
Topics: Animals; Dendritic Spines; Dizocilpine Maleate; Dose-Response Relationship, Drug; Emotions; Excitatory Amino Acid Agents; HEK293 Cells; Hippocampus; Humans; Learning; Male; Memory; Molecular Structure; Neuronal Plasticity; Oligopeptides; Pyramidal Cells; Pyrazines; Rats; Receptors, N-Methyl-D-Aspartate | 2018 |